ATE447585T1 - Antigener komplex, der ein immunstimulierendes peptid enthält, cd4 und chemokinrezeptor-domäne zur behandlung von hiv und immunerkrankungen - Google Patents

Antigener komplex, der ein immunstimulierendes peptid enthält, cd4 und chemokinrezeptor-domäne zur behandlung von hiv und immunerkrankungen

Info

Publication number
ATE447585T1
ATE447585T1 AT99930523T AT99930523T ATE447585T1 AT E447585 T1 ATE447585 T1 AT E447585T1 AT 99930523 T AT99930523 T AT 99930523T AT 99930523 T AT99930523 T AT 99930523T AT E447585 T1 ATE447585 T1 AT E447585T1
Authority
AT
Austria
Prior art keywords
hiv
stimulative
immuno
peptide
treatment
Prior art date
Application number
AT99930523T
Other languages
English (en)
Inventor
Chang Wang
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Application granted granted Critical
Publication of ATE447585T1 publication Critical patent/ATE447585T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99930523T 1998-06-20 1999-06-21 Antigener komplex, der ein immunstimulierendes peptid enthält, cd4 und chemokinrezeptor-domäne zur behandlung von hiv und immunerkrankungen ATE447585T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/100,409 US6090388A (en) 1998-06-20 1998-06-20 Peptide composition for prevention and treatment of HIV infection and immune disorders
PCT/US1999/014030 WO1999067294A1 (en) 1998-06-20 1999-06-21 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders

Publications (1)

Publication Number Publication Date
ATE447585T1 true ATE447585T1 (de) 2009-11-15

Family

ID=22279612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930523T ATE447585T1 (de) 1998-06-20 1999-06-21 Antigener komplex, der ein immunstimulierendes peptid enthält, cd4 und chemokinrezeptor-domäne zur behandlung von hiv und immunerkrankungen

Country Status (14)

Country Link
US (1) US6090388A (de)
EP (1) EP1098910B1 (de)
JP (1) JP4216473B2 (de)
CN (1) CN1207306C (de)
AT (1) ATE447585T1 (de)
AU (1) AU766955B2 (de)
BR (1) BRPI9912175B1 (de)
CA (1) CA2330235C (de)
DE (1) DE69941625D1 (de)
DK (1) DK1098910T3 (de)
ES (1) ES2336393T3 (de)
TW (1) TWI227242B (de)
WO (1) WO1999067294A1 (de)
ZA (1) ZA200006385B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417324B1 (en) * 2000-04-21 2002-07-09 Tripep Ab Synthetic peptides that bind to the hepatitis B virus core and e antigens
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6660842B1 (en) * 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6040137A (en) * 1995-04-27 2000-03-21 Tripep Ab Antigen/antibody specification exchanger
US7314632B1 (en) * 1997-07-11 2008-01-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pseudomonas exotoxin A-like chimeric immunogens
ES2249838T3 (es) * 1997-07-11 2006-04-01 The Government Of The Usa As Represented By The Secretary Of The Depar. Of Health And Human Services Inmunogenos quimericos similares a la exotoxina a de pseudomonas.
US20030054012A1 (en) * 2000-05-12 2003-03-20 Fitzgerald David J. Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response
TWI229679B (en) * 1998-06-20 2005-03-21 United Biomedical Inc Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
US7935805B1 (en) * 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
JP4776075B2 (ja) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 改変ｈｉｖｅｎｖポリペプチド
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
EP1307216A4 (de) * 2000-07-12 2005-01-12 Gryphon Therapeutics Inc Polymer-modifizierte bioaktive synthetische chemokine und methoden zu deren herstellung sowie verwendung
US7118737B2 (en) 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
AU2001273385B2 (en) * 2000-09-08 2005-04-07 Gryphon Therapeutics, Inc. Polymer-modified synthetic proteins
US20060116325A1 (en) * 2001-02-15 2006-06-01 Oleg Chertov Methods and compositions for inhibiting hiv-coreceptor interactions
US20040077835A1 (en) * 2001-07-12 2004-04-22 Robin Offord Chemokine receptor modulators, production and use
WO2003020876A2 (en) * 2001-08-31 2003-03-13 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US8088388B2 (en) * 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
CA2487831A1 (en) * 2002-06-11 2003-12-18 Glaxosmithkline Biologicals S.A. Immunogenic compositions
JP4630663B2 (ja) * 2002-08-13 2011-02-09 ハプトゲン リミテッド 抗ラクトンシグナル分子抗体または抗ラクトン由来シグナル分子抗体による感染性細菌症の治療のための方法
EP1594898A2 (de) 2003-02-06 2005-11-16 Tripep AB Glycosylierte spezifitätaustauscher
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
GB0407008D0 (en) * 2004-03-27 2004-04-28 Haptogen Ltd Methods for inducing rapid cell death (autolysis) in infectious bacteria
GB0410958D0 (en) * 2004-05-15 2004-06-16 Haptogen Ltd Methods for reducing biofilm formation in infectious bacteria
US9340601B2 (en) * 2007-03-01 2016-05-17 The Board Of Trustees Of The Leland Stanford Junior University Splice variants of the EGF receptor
US20090092631A1 (en) * 2007-03-26 2009-04-09 Tripep Ab Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
US8501907B2 (en) 2007-08-10 2013-08-06 Janssen Biotech, Inc. Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
ITPA20080007A1 (it) * 2008-03-19 2009-09-20 Angela Bonura Fattore anti - lps da parietaria judaica e suoi metodi di utilizzo.
US8329188B2 (en) * 2008-11-12 2012-12-11 Theraclone Sciences, Inc. Human M2e peptide immunogens
US20110305670A1 (en) * 2010-06-10 2011-12-15 President And Fellows Of Harvard College Nucleic acid encoding fusion polypeptides that prevent or inhibit hiv infection
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
MX2013005646A (es) * 2010-11-19 2013-08-01 Janssen Biotech Inc Composiciones de vacuna de fragmentos de clivaje de la inmunoglobulina.
CN102380094B (zh) * 2011-10-11 2013-08-07 中国科学院微生物研究所 特异多肽在制备狂犬病疫苗中的应用
MX2017003546A (es) 2014-09-16 2017-08-14 Ubi Ip Holdings Tratamiento y curacion fucional de la infeccion por vih por anticuerpos monoclonales para cd4, que median la inhibicion competitiva de la entrada de vih.
WO2018035001A1 (en) 2016-08-13 2018-02-22 United Biomedical, Inc. Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients
CN108640977A (zh) * 2018-06-18 2018-10-12 上海大学 特异性结合HIV上包膜糖蛋白gp120的多肽及其应用
CN113318225B (zh) * 2020-02-28 2024-01-19 无锡派列博生物医药科技有限公司 肿瘤免疫增强剂及其制法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0768273B2 (ja) * 1988-12-02 1995-07-26 カルピス食品工業株式会社 抗ｈｉｖペプチド
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
CA2161445C (en) * 1993-04-27 2009-06-30 Anna Efim Ladd Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines
WO1995011998A1 (en) * 1993-10-26 1995-05-04 United Biomedical, Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
AU2195395A (en) * 1994-03-28 1995-10-17 United Biomedical Inc. Synthetic peptide based immunogens for the treatment of allergy
ATE335835T1 (de) * 1996-06-03 2006-09-15 United Biomedical Inc Antikörper gegen einen komplex aus cd4 und einer chemokinrezeptordomäne, sowie deren verwendung gegen hiv infektionen

Also Published As

Publication number Publication date
ES2336393T3 (es) 2010-04-12
CN1207306C (zh) 2005-06-22
WO1999067294A1 (en) 1999-12-29
EP1098910A1 (de) 2001-05-16
CA2330235A1 (en) 1999-12-29
TWI227242B (en) 2005-02-01
DK1098910T3 (da) 2010-02-01
JP4216473B2 (ja) 2009-01-28
HK1036805A1 (en) 2002-01-18
BRPI9912175B8 (de) 2021-07-06
JP2002518523A (ja) 2002-06-25
CN1303394A (zh) 2001-07-11
DE69941625D1 (de) 2009-12-17
BRPI9912175A (pt) 2001-04-10
EP1098910A4 (de) 2005-02-02
AU766955B2 (en) 2003-10-30
CA2330235C (en) 2008-08-12
AU4704899A (en) 2000-01-10
US6090388A (en) 2000-07-18
EP1098910B1 (de) 2009-11-04
BRPI9912175B1 (pt) 2019-08-27
ZA200006385B (en) 2001-10-11

Similar Documents

Publication Publication Date Title
ATE447585T1 (de) Antigener komplex, der ein immunstimulierendes peptid enthält, cd4 und chemokinrezeptor-domäne zur behandlung von hiv und immunerkrankungen
EP1090039A4 (de) Peptidzusammensetzung als immunogen zur allergiebehandlung.
Widmann et al. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides
CA2135833C (en) Antigen carbohydrate compounds and their use in immunotherapy
TW514530B (en) Tumor vaccines and methods for their production
DK0810870T3 (da) Isolerede, MAGE-2-afledte tumorafstødelsesantigenpræcurserpeptider og anvendelse heraf
EP0529023A1 (de) Therapeutisch nützliche peptide und peptidfragmente
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
RU2009101191A (ru) Sparc-производные антигенные пептиды отторжения опухоли и лекарственные средства, содержащие их
EP3829571B1 (de) Adjuvante wirkung des tlr1/2-agonisten disprovocim in synergie mit checkpoint-inhibierenden antikörpern zur bekämpfung von infektiösen oder kanzerösen krankheiten
US10172925B2 (en) Uses of partial peptides of survivin and variations thereof
AP502A (en) Multiple branch peptide constructions for use against HIV.
CA2128407C (en) Synthetic peptides for a rubella vaccine
Hosmalin et al. Immunization with soluble protein-pulsed spleen cells induces class I-restricted cytotoxic T lymphocytes that recognize immunodominant epitopic peptides from Plasmodium falciparum and HIV-1
Frassanito et al. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte
WO2005049072A2 (en) Therapeutic cancer vaccine with fragments of trag-3
JPH05506039A (ja) 治療に有用なペプチドおよびペプチド断片
CN101374857A (zh) 新的t辅助细胞抗原决定簇（thd）肽
AU707739B2 (en) Suppressor T-cell hybridoma
CA2103046A1 (en) Suppressor t-cell hybridoma
Hampton Identification and characterization of tumor-associated antigens
HK1149781A (en) Partial peptide of survivin presented on mhc class ii molecule and use thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1098910

Country of ref document: EP